导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 4.89% | 380/1050 |
| 近一周 | -2.17% | 477/1104 |
| 近一月 | -3.61% | 425/1102 |
| 近一季 | -8.85% | 617/1092 |
| 近半年 | -1.89% | 472/1070 |
| 近一年 | 9.31% | 361/1018 |
| 近两年 | 58.27% | 444/926 |
| 近三年 | 56.37% | 216/834 |
| 成立以来 | 93.02% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
1.39% 392/1070 |
17.60% 412/1101 |
- - |
- - |
| 2025 | 27.13% 531/1065 |
-0.27% 810/1014 |
3.47% 399/1038 |
21.50% 559/1050 |
1.40% 357/1065 |
| 2024 | 11.14% 262/1011 |
1.09% 258/960 |
-0.97% 375/983 |
14.26% 276/991 |
-2.83% 519/1011 |
| 2023 | -6.39% 235/952 |
5.70% 276/880 |
-1.77% 290/895 |
-12.13% 686/915 |
2.61% 53/952 |
| 2022 | -29.45% 614/867 |
-22.95% 667/773 |
20.03% 23/806 |
-16.41% 645/845 |
-8.73% 756/867 |
| 2021 | 25.88% 106/740 |
-1.75% 214/580 |
14.86% 238/659 |
3.64% 152/704 |
7.63% 132/740 |
| 2020 | 43.82% 275/554 |
-9.51% 377/419 |
13.76% 369/466 |
10.28% 247/517 |
26.68% 55/554 |
| 2019 | - - |
- - |
- - |
- - |
5.80% 318/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 鹏扬元合量化大盘A VS. 东吴新产业精选股票A(580008) |